Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2010
11/24/2010EP2252278A2 Compounds for use in the treatment of neuropathic pain
11/24/2010EP2252268A1 Pulmonary formulations of triptans
11/24/2010EP2252263A1 Galenic form for the oral transmucosal delivery of triptans
11/24/2010EP2252246A1 Chemoprotective methods and compositions
11/24/2010EP2252151A1 Quinolizidinone m1 receptor positive allosteric modulators
11/24/2010EP2091531B1 Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting mpt
11/24/2010EP2089015B1 Methods for treating disruptive behavior disorders
11/24/2010EP2040700B1 N- (phenylmethyl) -2- (1h-pyraz0l-4-yl) acetamide derivatives as p2x7 antagonists for the treatment of pain, inflammation and neurodegeneration
11/24/2010EP1970055B1 Multi-layered tablet with triple release combination
11/24/2010EP1934216B1 Naphthyridin derivatives
11/24/2010EP1891006B1 Inhibitors of cytosolic phospholipase a2
11/24/2010EP1883451B1 Substituted indole compounds having nos inhibitory activity
11/24/2010EP1546375B1 Nucleic acids, polypeptides, and methods for modulating apoptosis
11/24/2010EP1497285B1 Benzoxazinone-derived compounds, their preparation und use as medicaments
11/24/2010EP1326896B1 Human anti-cd40 antibodies
11/24/2010CN201641306U Neck-protection sleep-assistant health care pillow
11/24/2010CN1955159B Composite for blocking 5-hydroxytryptamine and norepinephrine reabsorbed, its preparation method and its use
11/24/2010CN1942181B Tablet containing branched chain amino acid and process for producing the same
11/24/2010CN1935253B Cerebral proteolysis dispersible tablet and its preparing method
11/24/2010CN1925859B 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as GABA receptor ligands for the treatment of anxiety, depression and epilepsy
11/24/2010CN1913900B Amino bustituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders
11/24/2010CN1808106B Method for screening acetylcholine esterase inhibitor by nuclear magnetic resonance
11/24/2010CN101896480A Tetrazole derivatives as modulators of metabotropic glutamate receptors (MGLURS)
11/24/2010CN101896461A Gamma secretase modulators
11/24/2010CN101896456A Process for the production of 2-[4-(3- or 2-fluorobenzyloxy)benzylamino]propanamides with high purity degree
11/24/2010CN101896452A Carbon linked modulators of gamma-secretase
11/24/2010CN101892249A Pufa polyketide synthase systems and uses thereof
11/24/2010CN101891822A Fusion polypeptide use for preventing and treating senile dementia by brain barrier permeability
11/24/2010CN101891738A Dasatinib polymorph and preparation method and medical composite thereof
11/24/2010CN101891706A 3,4-dihydrobenzo[f][1,4]thiazepine compound or salts of same and medical use of same
11/24/2010CN101891680A Modulators of atp-binding cassette transporters
11/24/2010CN101890166A Combination of organic compounds
11/24/2010CN101890163A Use of anti-tnfalpha antibodies and another drug
11/24/2010CN101890142A Chinese medicinal composition for curing somnolence and preparation method thereof
11/24/2010CN101890135A Antidepressant traditional Chinese medicine composition and application thereof
11/24/2010CN101890132A Plaster for wry mouth and heterotropia
11/24/2010CN101890118A Smoking cessation pure natural plant tobacco substituting extract, product thereof and preparation method thereof
11/24/2010CN101890104A Chinese medicament for treating neck, shoulder, waist and leg pains
11/24/2010CN101890088A Chinese medicinal composition for treating insomnia
11/24/2010CN101890083A Constraint eliminating and menstruation regulating wine
11/24/2010CN101890082A Medicinal composition for treating depression and manufacturing method thereof
11/24/2010CN101890077A Preparation method and quality detection method of rhizoma corydalis pain relieving soft capsules
11/24/2010CN101890071A Method for identifying Gentiana rigescens Franch and Gentiana manshurica Kitag medicinal materials
11/24/2010CN101890061A Method for preparing ginkgo biloba leaf extract injection, and ginkgo biloba leaf extract injection
11/24/2010CN101890033A Application of paederosidic acid used for preparing analgesic drugs and/or anti-inflammatory drugs
11/24/2010CN101890032A Medicine composition for treating depression with formulation of Rg1, Rb1 and glycyrrhizic acid and preparation method thereof
11/24/2010CN101890030A Composite capable of preventing bacteria, viruses, oxidation and pigment deposition
11/24/2010CN101890019A Use of dihydroimidazolones for the treatment of epilepsy in dogs
11/24/2010CN101889986A Flunarizine orally disintegrating tablet and preparation method thereof
11/24/2010CN101889977A Pyritinol hydrochloride injection and preparation method thereof
11/24/2010CN101244231B Chinese medicine fragrant composition, its preparation and application
11/24/2010CN101229132B Nimodipine pulse sustained release mircopill preparation and preparing method thereof
11/24/2010CN101181305B Extract of acaleph toxin as well as preparation method and usage thereof
11/24/2010CN101155787B (3,4-dihydro-quinazolin-2-yl)-indan-1-yl-amines
11/24/2010CN101129365B Analgesics use of ricinine
11/24/2010CN101045715B Heterocycle inhibitor for glycogen synthase kinase gsk-3
11/23/2010US7838637 Single-chain multiple antigen-binding molecule, its preparation and use
11/23/2010US7838565 Suppresses reduction in peripheral nerve conduction rate and alleviates hypofunction of bladder so that it is useful as a preventive and/or therapeutic agent for, particularly, diabetic neuropathy
11/23/2010US7838555 Useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and
11/23/2010US7838541 Methods of using aryl ureas to treat diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes.
11/23/2010US7838518 1-(4-methoxynaphthalene-1-sulfonyl)-2,3-dihydro-1H-indole-3-carboxylic acid [2-(1-methyl-pyrrolidin-2-yl)-ethyl]amide; selective affinity for 5-HT6 receptor; psychosis, schizophrenia, depression, neurological disorders, cognitive enhancement, Parkinson's disease, ALS, Alzheimer's, Huntington's disease
11/23/2010US7838289 Assay utilizing multipotent adult stem cells
11/23/2010US7838247 determination of the Alzheimer Related Membrane Protein (ARMP) gene on chromosome 14 and a related gene, E5-1, on chromosome 1; diagnosing Alzheimer's disease
11/23/2010US7838043 administering scavenger of superoxide anion or nitric oxide comprising fine powder of platinum (colloid) which is prepared by metal salt reduction in presence of water-soluble polymer comprising polyvinylpyrrolidone, polyvinyl alcohol, polyacrylic acid, cyclodextrin, amylopectin, and methylcellulose
11/23/2010US7837987 Fusion using polyoxyalkylene glycol
11/23/2010US7836883 Methods for treating rhinitis and conjunctivitis
11/23/2010CA2799515A1 Delayed release rasagiline formulation
11/23/2010CA2727899A1 Delayed release rasagiline formulation
11/23/2010CA2480776C Methods of preparation of the 2-(7-chloro-1,8-naphthyridine-2yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone
11/23/2010CA2480239C Method for manufacture of sertindole
11/23/2010CA2461068C Cell populations which co-express cd49c and cd90
11/23/2010CA2440014C Beta-carboline derivatives and its pharmaceutical use against depression and anxiety
11/23/2010CA2438870C Novel inhibitors of formation of advanced glycation endproducts (ages)
11/23/2010CA2433585C Pharmaceutical compositions containing donepezil hydrochloride
11/23/2010CA2342200C Use of certain drugs for treating nerve root injury
11/23/2010CA2169292C Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
11/23/2010CA2158791C Dna sequences encoding the machado-joseph disease gene and uses thereof
11/18/2010WO2010132882A2 Sublingual dexmedetomidine compositions and methods of use thereof
11/18/2010WO2010132873A2 Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthase
11/18/2010WO2010132821A2 Methods and compositions for treating degenerative and ischemic disorders
11/18/2010WO2010132696A1 Ranolazine for the treatment of cns disorders
11/18/2010WO2010132691A1 Oligomer-containing substituted aromatic triazine compounds
11/18/2010WO2010132609A2 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory
11/18/2010WO2010132521A1 Compositions comprising transnorsertraline and serotonin receptor 1a agonists/ antagonists and uses thereof
11/18/2010WO2010132423A1 Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptors in combination with acetylcholinesterase inhibitors
11/18/2010WO2010132352A2 Spiro compounds and their use as therapeutic agents
11/18/2010WO2010132015A1 New compounds modulating gamma-secretase and their use in the treatment of alpha beta related pathologies, such as alzheimer's disease
11/18/2010WO2010131717A1 Prion protein structure transformation inhibitor and utilization of same
11/18/2010WO2010131695A1 Modified double-stranded rna
11/18/2010WO2010131191A1 Thiazolidin-4-one and [1,3]-thiazinan-4-one compounds as orexin receptor antagonists
11/18/2010WO2010131038A2 Steroid containing composition and uses thereof
11/18/2010WO2010130977A1 Methods of chemical synthesis of diaminophenothiazinium compounds involving the use of persulfate oxidants
11/18/2010WO2010130946A1 Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
11/18/2010WO2010130945A1 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof, and therapeutic use thereof
11/18/2010WO2010130943A1 5-membered heterocyclic compound cyclopenta[c]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof
11/18/2010WO2010130934A2 2-cycloamino-5-(pyridin-4-yl)imidazo[2,1-b][1,3,4]thiadiazole derivatives, preparation thereof, and therapeutic use thereof
11/18/2010WO2010130799A2 Method for impregnation with supercritical co2
11/18/2010WO2010130768A1 Novel 1,4-diaza-bicyclo[3.2.1]octane derivatives useful as nicotinic acetylcholine receptor modulators
11/18/2010WO2010130672A1 Azabicyclo [4.1.0] heptane derivatives and their use as monoamine reuptake inhibitors
11/18/2010WO2010130646A1 Lactoferrin and brain health and protection in adults
1 ... 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 ... 1833